Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 229Squamous Cell Carcinoma of Head and Neck 138Head and Neck Neoplasms 130Lung Neoplasms 117Esophageal Neoplasms 88Stomach Neoplasms 84Uterine Cervical Neoplasms 66Esophageal Squamous Cell Carcinoma 65Urinary Bladder Neoplasms 59Breast Neoplasms 55Nasopharyngeal Carcinoma 51Small Cell Lung Carcinoma 46Carcinoma, Squamous Cell 39Neoplasm Metastasis 38Pancreatic Neoplasms 36Neoplasms 35Biliary Tract Neoplasms 34Oropharyngeal Neoplasms 32Cholangiocarcinoma 32Ovarian Neoplasms 30Mesothelioma, Malignant 28Adenocarcinoma Of Esophagus 28Lymphoma 25Carcinoma 24Adenocarcinoma of Lung 24Central Nervous System Neoplasms 22Laryngeal Neoplasms 20Carcinoma, Ovarian Epithelial 20Recurrence 19Lymphoma, Large B-Cell, Diffuse 19

Interventions

Oxaliplatin 5Capecitabine 5Paclitaxel 4apatinib 3Fluorouracil 3Docetaxel 3Cisplatin 3S 1 (combination) 2Leucovorin 2titanium silicide 1rucaparib 1relatlimab 1raltitrexed 1pazopanib 1olaparib 1linrodostat 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1camrelizumab 1Sunitinib 1SHR-1701 1Nivolumab 1Ipilimumab 1HMPL-013 1Epirubicin 1Doxorubicin 1CF regimen 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Advanced Gastric Cancer × Cisplatin × Clear all
NCT01471470 2020-01-07

Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

Asan Medical Center

Phase 2 Completed
31 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT00842491 2015-05-19

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

Peking University

Phase 2 Completed
45 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT00743964 2010-01-15

Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)

Samsung Medical Center

Phase 2 Completed
91 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡